BSE filing, NSE: ESABINDIA. Summary written from the filing by ALFA Finder's alert engine.
Esab India Ltd: key numbers
- Share price
- ₹5,249.00
- Market cap
- ₹8,080 Cr
- Revenue (annual)
- ₹1,508 Cr
- Net profit (annual)
- ₹206.7 Cr
- P/E (TTM)
- 36.4×Sector 52.0×
- Promoter holding
- 73.72%+0.00% QoQ
- FII holding
- 1.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Esab India Ltd
All →Esab India Other Announcement
Esab India Ltd submitted its quarterly shareholding pattern under Regulation 31 for the period ended September 30, 2026.
Esab India Board Meeting Date
ESAB India Ltd will hold a board meeting on 4th November 2026 to consider unaudited financial results and a potential interim dividend.
Esab India Legal & Regulatory
ESAB India Ltd reports that the Commissioner of Income Tax (Appeals) has dismissed its appeals against tax penalty orders totaling ₹1.45 Crore. The company plans further appeals.
- Value
- ₹1.45 Cr
Esab India Q1 FY27 Results: Net Profit ₹56.1 Cr, Up 37.2% YoY
Esab India Ltd reported revenue from operations of ₹421.1 Cr (+19.6% YoY) and net profit of ₹56.1 Cr (+37.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹56.1 Cr · +37.2% YoY
Esab India Management Change
ESAB India announced the retirement of Biswadeep Banerjee as General Manager and the additional charge assignment for Jalubula Venkata Koteswara Rao within senior management.
Esab India Annual Report
ESAB India Ltd has submitted a revised Annual Report for the financial year 2025-26. The revision corrects minor inadvertent errors in waste management figures.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.